Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 109889.ª Legislatura (2025)

Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

House Committee Report

El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.

 
 
  By: Blanco, et al. S.B. No. 1098
 
  (Hull)
 
   
 
  A BILL TO BE ENTITLED
  AN ACT
  relating to the disclosure by a pharmacy to a patient of certain
  price information for a drug or biological product.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 562.003, Occupations Code, is amended to
  read as follows:
         Sec. 562.003.  DISCLOSURE OF PRICE; PATIENT'S OPTION.  (a)  A
  pharmacy shall disclose the lowest cost cash price at that pharmacy
  for the drug or biological product prescribed to the patient.
         (b)  If the price of a drug or biological product to a patient
  is lower than the amount of the patient's copayment under the
  patient's prescription drug insurance plan, the pharmacist shall
  offer the patient the option of paying for the drug or biological
  product at the lower price instead of paying the amount of the
  copayment.
         SECTION 2.  This Act takes effect September 1, 2025.

Texto oficial de la Legislatura de Texas. El formato se adaptó para leerlo en Ratifi.